Deal coming imo - Confirmed (multiple parties for both) ZIOP not only cancelled the coming out party at Jefferies Immuno-Oncology Summit, - but also today's (Tues) Cancer Advance Boston appearance....
Deal and all time highs coming IMO....ZIOP cancelled the presentation Weds at the important Jefferies Immuno-Oncology Summit, Boston 4/15 & confirmed with 3 people the presentation at Cancer Advance Boston (see bottom of post for details) ZIOP appearance also cancelled
Deal coming imo in the next few weeks....late stage heavy negotiations IMO caused this cancellation of the ....next deal sends us to ALL TIME HIGHS and there is a possibility those deal discussions have turned into takeover discussions......its CRAZY this stock is still $10 after the NCI deal with Steven Rosenberg the Godfather of CAR T. Round out you positions...Shorts one warning and I am serious...cover now.
Cancer Advance Boston will hopefully kick off the information season in biotech.
Cancer Advance Boston - April 13, 2015
1:50-2:30 pm Paradigm Shift: T Cell Therapies
Arie Belldegrun, Kite Pharma;
André CHOULIKA, Cellectis;
Tom Farrell, Bellicum Pharmaceuticals;
Jonathan Lewis, Ziopharm Oncology (CANCELLED)
Moderator: Biren Amin, Jefferies
Clarion Healthcare LLC, Foundation Medecine, EMD seron
Cancer Advance Boston Brings Together Leading Oncology Experts on April 13th and 14th
Prominent academics, leaders of the biopharmaceutical industry and key investors will gather on April 13th and 14th for Cancer Advance Boston, a networking conference of the Boston Biotech Conference series. Cancer Advance Boston will take place at the Joseph B. Martin Conference Center at Harvard Medical School and will focus on the latest developments in oncology R&D.
Panels will discuss compassionate use, immunotherapy (including T cell therapy), combination therapy, building successful partnerships, biomarkers and more. Panelists include Rafael Amado (Adaptim